Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 158,313Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Breckenridge Pharmaceutical

02 3Strides Pharma Science

03 22care4

04 1ARCUTIS CANADA, INC.

05 2Alkem Laboratories

06 3Arcutis Biotherapeutics

07 8AstraZeneca

08 1Aurobindo Pharma Limited

09 2Hetero Drugs

10 1KMS Health Center

11 1MS Pharma

12 2MSN Laboratories

13 2Micro Labs Limited

14 2ORIFARM GROUP AS

15 1Orchid Pharma

16 1Precise Group

17 1Prinston

18 4Takeda Pharmaceutical

19 4Torrent Pharmaceuticals Limited

20 1Viatris

21 2Zydus Pharmaceuticals

22 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-10-03

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

Breckenridge Pharmaceutical

02

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2020-03-30

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

03

arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-10-19

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

Breckenridge Pharmaceutical

04

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-06-20

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

05

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Roflumilast

Brand Name :

Dosage Form : Tablet

Dosage Strength : 500MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 212490

Regulatory Info : RX

Registration Country : USA

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 212490

Regulatory Info : RX

Registration Country : USA

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.3%

Packaging :

Approval Date : 2022-07-29

Application Number : 215985

Regulatory Info : RX

Registration Country : USA

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.15%

Packaging :

Approval Date : 2024-07-09

Application Number : 215985

Regulatory Info : RX

Registration Country : USA

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Dosage Form : FOAM;TOPICAL

Dosage Strength : 0.3%

Packaging :

Approval Date : 2023-12-15

Application Number : 217242

Regulatory Info : RX

Registration Country : USA

blank

11

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2011-02-28

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

12

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2018-01-23

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

13

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2023-04-17

Application Number : 213298

Regulatory Info : RX

Registration Country : USA

blank

14

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-11-23

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

15

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

16

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2019-03-22

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

17

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

18

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Roflumilast

Brand Name :

Dosage Form : TABLET

Dosage Strength : 500MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, BE- Available

Registration Country : Jordan

blank

19

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

20

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

21

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Roflumilast

Brand Name :

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

22

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-05-10

Application Number : 208299

Regulatory Info : RX

Registration Country : USA

blank

23

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

roflumilast

Brand Name : Daliresp

Dosage Form : FILM COATED PILL

Dosage Strength : 500 MICROGRAMS

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

24

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

roflumilast

Brand Name : Daxas

Dosage Form : FILM COATED PILL

Dosage Strength : 500 MICROGRAMS

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

25

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

roflumilast

Brand Name : Libertek

Dosage Form : FILM COATED PILL

Dosage Strength : 500 MICROGRAMS

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

26

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-08-06

Application Number : 208272

Regulatory Info : DISCN

Registration Country : USA

blank

27

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2024-10-18

Application Number : 208272

Regulatory Info : RX

Registration Country : USA

blank

28

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-07-13

Application Number : 208257

Regulatory Info : RX

Registration Country : USA

blank

29

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-02-10

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank

30

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank